{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:16:48Z","timestamp":1791375408428,"version":"4.3.1"},"reference-count":20,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TCRM"],"DOI":"10.2147\/tcrm.s481128","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T07:10:11Z","timestamp":1732864211000},"page":"799-809","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of Efficacy and Safety Outcomes of Different Doses Schedules of Thalidomide for Treating Moderate-to-Severe \u03b2-Thalassemia Patients"],"prefix":"10.2147","volume":"Volume 20","author":[{"given":"Wei-Jia","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian-dong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-ming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,11]]},"reference":[{"key":"ref1","unstructured":"Eleftheriou A, Angastiniotis M. Global thalassaemia review 2021. Nicosia: Thalassaemia International Federation, 2021."},{"key":"ref2","unstructured":"Beijing Angel Mom Charity Foundation & Beijing Normal University, China Philanthropy Research Institute. China thalassemia blue book: report on the prevention and treatment of thalassemia in China (2020). Beijing: China Social Publishing House, 2021."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.3760\/cma.j.issn.0254-6450.2019.12.009","volume":"40","author":"Baiqing","year":"2019","journal-title":"Chin J Epidemiol"},{"key":"ref4","first-page":"37","volume":"10","author":"Jalali","year":"2016","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/blood-2007-01-065201","volume":"110","author":"Aerbajinai","year":"2007","journal-title":"Blood"},{"key":"ref6","unstructured":"The Hematology Group of the Pediatric Branch of the Chinese Medical Association, Editorial Committee of Chinese Journal of Pediatrics. Diagnosis and treatment guidelines of \u03b2-thalassemia major. Chin J Pediatr. 2018;56(10):724\u2013729. doi:10.3760\/cma.j.issn.0578-1310.2018.10.002"},{"key":"ref7","unstructured":"Guangdong Association for the Prevention and Treatment of \u03b2-thalassemia, Editorial Committee of Chinese Journal of Practical Pediatrics. Expert consensus on the diagnosis, treatment, and management of non transfusion dependent thalassemia in children. Chinese J Practical Pediatr. 2018;33(12):929\u2013934."},{"key":"ref8","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE)version 5.0: Published November 27, 2017.U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e2020021","DOI":"10.4084\/mjhid.2020.021","volume":"12","author":"Yang","year":"2020","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"13592","DOI":"10.1038\/s41598-023-40849-4","volume":"13","author":"Ali","year":"2023","journal-title":"Sci Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e30391","DOI":"10.1002\/pbc.30391","volume":"70","author":"Jian","year":"2023","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00277-018-3395-5","volume":"97","author":"Ren","year":"2018","journal-title":"Ann Hematol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/ajh.27189","volume":"99","author":"Pinto","year":"2024","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.2147\/IJGM.S462991","volume":"17","author":"Zhu","year":"2024","journal-title":"Int J Gen Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"814302","DOI":"10.3389\/fphar.2021.814302","volume":"11","author":"Lu","year":"2022","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"635670","DOI":"10.1155\/2015\/635670","volume":"2015","author":"Barcellini","year":"2015","journal-title":"Dis Markers"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s13312-021-2254-y","volume":"58","author":"Chandra","year":"2021","journal-title":"Indian Pediatr"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102544","DOI":"10.1016\/j.bcmd.2021.102544","volume":"88","author":"Jain","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bcmd.2016.01.003","volume":"57","author":"Ricchi","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"ref20","unstructured":"Wu Y Clinical observation of reduced maintenance therapy with thalidomide for non transfusion dependent thalassemia. Guilin Medical College.2021.5."}],"container-title":["Therapeutics and Clinical Risk Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/article\/download\/97840","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/article\/download\/97840","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T07:10:17Z","timestamp":1732864217000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/comparison-of-efficacy-and-safety-outcomes-of-different-doses-schedule-peer-reviewed-fulltext-article-TCRM"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":20,"URL":"https:\/\/doi.org\/10.2147\/tcrm.s481128","relation":{},"ISSN":["1178-203X"],"issn-type":[{"value":"1178-203X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}